Zengying Wang
Overview
Explore the profile of Zengying Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen J, Shan W, Jia Q, Chen Y, Jiang W, Tian Y, et al.
Oncogene
. 2024 Sep;
43(43):3170-3183.
PMID: 39256572
Post-translational modifications of proteins play a pivotal role in both the initiation and progression of ovarian cancer. Despite the recognition of USP33 as a significant factor in various cancers, its...
2.
Wu H, Wang Z, Wang P, Meng Y, Wang Z, Xue Y, et al.
J Ophthalmol
. 2024 Jul;
2024:3684626.
PMID: 38957378
Objective: To assess repeatability and agreement of central vault for implantable collamer lens (ICL) measured by the Tomey OA-2000 biometry and Spectralis optical coherence tomography (OCT). Methods: In this prospective...
3.
Shan W, Peng W, Chen Y, Wang Y, Yu Q, Tian Y, et al.
Oncogene
. 2024 Apr;
43(25):1885-1899.
PMID: 38664501
Receptor-interacting protein kinase 4 (RIPK4) is increasingly recognized as a pivotal player in ovarian cancer, promoting tumorigenesis and disease progression. Despite its significance, the posttranslational modifications dictating RIPK4 stability in...
4.
Bai X, Wei X, Wang Z, Zhang M
Neural Netw
. 2024 Jan;
172:106109.
PMID: 38232431
Human pose estimation has numerous applications in motion recognition, virtual reality, human-computer interaction, and other related fields. However, multi-person pose estimation in crowded and occluded scenes is challenging. One major...
5.
Wang Z, Wang P, Jiang B, Meng Y, Qie S, Yan Z
PLoS One
. 2023 Jul;
18(7):e0282286.
PMID: 37494360
Objective: To evaluate the efficacy and safety of 0.01% atropine alone and in combination with orthokeratology for myopia control using a meta-analysis. Methods: PubMed, Cochrane Library, and EMBASE were searched....
6.
Wang Z, Wang Z, Meng Y, Wang P, Yibulayin S, Jiang B, et al.
Heliyon
. 2023 Apr;
9(4):e14887.
PMID: 37025848
Aims: the aim of this study to investigate the elevation changes in posterior corneal surface after 12 months of orthokeratology (ortho-k) treatment. Methods: In this retrospective chart review, medical records...
7.
Zhao F, Wang Z, Li Z, Liu S, Li S
Front Immunol
. 2022 Oct;
13:980508.
PMID: 36275729
Lactic acid, once considered as an endpoint or a waste metabolite of glycolysis, has emerged as a major regulator of cancer development, maintenance, and progression. However, studies about lactic acid...
8.
Zhao F, Li Z, Dong Z, Wang Z, Guo P, Zhang D, et al.
Front Immunol
. 2022 Jul;
13:918154.
PMID: 35880180
Accumulating studies have demonstrated the indispensable roles of exosomes and long non-coding RNAs (lncRNAs) in cancer progression and the tumor microenvironment (TME). However, the clinical relevance of exosome-related lncRNAs (ER-lncRNAs)...
9.
Wang Z, Meng Y, Wang Z, Hao L, Rashidi V, Sun H, et al.
Cont Lens Anterior Eye
. 2021 Nov;
45(4):101534.
PMID: 34772627
Aims: Considering individual variability in regards to the effects of orthokeratology (ortho-k) on myopia progression and controversies regarding the precise underlying mechanism, the aim of this study was to investigate...
10.
Zhao F, Wang Z, Gao Y, Wu Y, Liu J, He S
Evid Based Complement Alternat Med
. 2021 Feb;
2021:2693472.
PMID: 33603815
Objective: To compare the efficiency of transcutaneous electrical acupoint stimulation (TEAS) with those of conventional and TCM herb on bone marrow suppression in small cell lung cancer (SCLC) patients after...